Back to Search Start Over

Toxicity and Quality of Life Outcomes from a Randomized Phase II Trial of HDR Monotherapy for Low and Intermediate-Risk Prostate Cancer

Authors :
Y. Hasan
D.A. Loblaw
H.R. Chung
M. McGuffin
C.L. Tseng
L.C. Mendez
A. Ravi
L. Zhang
A. Mamedov
G. Morton
Source :
International Journal of Radiation Oncology*Biology*Physics. 105:S133
Publication Year :
2019
Publisher :
Elsevier BV, 2019.

Details

ISSN :
03603016
Volume :
105
Database :
OpenAIRE
Journal :
International Journal of Radiation Oncology*Biology*Physics
Accession number :
edsair.doi...........87ede793b8bb3e1cca43225067bd12fc
Full Text :
https://doi.org/10.1016/j.ijrobp.2019.06.120